CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 35 enrolled
Drug / intervention
PIPACdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02320448
NCT02320448Phase 2Completed
CompareCT.gov

Implementation and Evaluation of PIPAC for the Treatment of Patients With Peritoneal Carcinomatosis - a Feasibility Study.

Michael Bau Mortensen·interventional·Posted Dec 19, 2014·Updated Sep 12, 2017

In Brief

A Phase 2 clinical trial evaluating PIPAC for Peritoneal Carcinomatosis. Completed, enrolled 35 participants across 1 site.

Detailed Summary

This is a feasibility study that aims to evaluate whether PIPAC (Pressurized Intraperitoneal Aerosol Chemotherapy) is a safe and feasible treatment in Danish patients with peritoneal cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeritoneal Carcinomatosis
CountriesDenmark
Collaborators--

Timeline

Phase 2CompletedFinished
201520162017201820192020202120222023202420252026
First PostedDec 19, 2014
Enrollment StartMar 1, 2015
Primary CompletionAug 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 11.5 years ago

Interventions

PIPACdrug